In patients with advanced melanoma, nivolumab/relatlimab combination therapy shows a cutaneous irAEs prevalence of 21.5%, ...

Mass General Brigham, based in Somerville, Mass., is partnering with Philips to enhance real-time patient monitoring by integrating medical device data into a unified platform, a move aimed at ...

Menopause is something every woman goes through, but doctors — even OB-GYNs — aren't required to learn much about it. Why it ...

A union could address a host of issues, including cost-of-living raises, paid sick time, and a definition of “full-time work” ...

For decades, the idea that creativity comes from the right side of the brain has dominated popular culture. People have been told they're either "right-brained" (creative, intuitive) or "left-brained" ...

Mass General Brigham — then called Partners HealthCare — sparked an uproar when it announced plans to build outpatient ...

Marlise R. Luskin, MD, MSCE, discusses the trial of tagraxofusp in BPDCN, which showed high response rates and overall survival.

Dr. Yvon Woappi, a 2011 University of Pittsburgh at Bradford graduate who researches wound healing and regeneration at his ...

A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By ...

Dr. Yvon Woappi ’11, who researches wound healing and regeneration at his lab at Columbia University, will address the ...

The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

Cross-sectional data showed that physicians in the U.S. had lower mortality rates than the general population. Physicians in ...